213 related articles for article (PubMed ID: 25426939)
1. Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China.
Zhu Q; Wang L; Lin W; Bulterys M; Yang W; Sun D; Cui Z; Kaplan J; Kleinman N; Wei X; Chung J; Wang Z
Curr HIV Res; 2014; 12(5):359-65. PubMed ID: 25426939
[TBL] [Abstract][Full Text] [Related]
2. [Effect of co-trimoxazole prophylaxis used for AIDS patients under anti-retroviral therapy].
Yang W; Liang Y; Li J; Ma Y; Li N; Sun D; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):689-94. PubMed ID: 25174473
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
Hakim J; Musiime V; Szubert AJ; Mallewa J; Siika A; Agutu C; Walker S; Pett SL; Bwakura-Dangarembizi M; Lugemwa A; Kaunda S; Karoney M; Musoro G; Kabahenda S; Nathoo K; Maitland K; Griffiths A; Thomason MJ; Kityo C; Mugyenyi P; Prendergast AJ; Walker AS; Gibb DM;
N Engl J Med; 2017 Jul; 377(3):233-245. PubMed ID: 28723333
[TBL] [Abstract][Full Text] [Related]
4. Effects of cotrimoxazole prophylaxis on
Jiang J; Qin F; Meng S; Nehl EJ; Huang J; Liu Y; Zou J; Dong W; Huang J; Chen H; Zang N; Liang B; Ning C; Liao Y; Luo C; Liu H; Liu X; Wang J; Zhou O; Le T; Ye L; Wu F; Liang H
Emerg Microbes Infect; 2019; 8(1):367-376. PubMed ID: 31851879
[TBL] [Abstract][Full Text] [Related]
5. [Survival analysis on Former Plasma Donors living with HIV/AIDS after initiation of antiretroviral therapy in Henan province, 2002-2017].
Liang Y; Yang WJ; Sun DY; Li N; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):638-642. PubMed ID: 31238611
[No Abstract] [Full Text] [Related]
6. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
Walker AS; Ford D; Gilks CF; Munderi P; Ssali F; Reid A; Katabira E; Grosskurth H; Mugyenyi P; Hakim J; Darbyshire JH; Gibb DM; Babiker AG
Lancet; 2010 Apr; 375(9722):1278-86. PubMed ID: 20347483
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
Bwakura-Dangarembizi M; Kendall L; Bakeera-Kitaka S; Nahirya-Ntege P; Keishanyu R; Nathoo K; Spyer MJ; Kekitiinwa A; Lutaakome J; Mhute T; Kasirye P; Munderi P; Musiime V; Gibb DM; Walker AS; Prendergast AJ
N Engl J Med; 2014 Jan; 370(1):41-53. PubMed ID: 24382064
[TBL] [Abstract][Full Text] [Related]
9. Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya.
Kohler PK; Chung MH; McGrath CJ; Benki-Nugent SF; Thiga JW; John-Stewart GC
AIDS; 2011 Aug; 25(13):1657-61. PubMed ID: 21673562
[TBL] [Abstract][Full Text] [Related]
10. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.
Badri M; Ehrlich R; Wood R; Maartens G
AIDS; 2001 Jun; 15(9):1143-8. PubMed ID: 11416716
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
[TBL] [Abstract][Full Text] [Related]
12. Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.
Zhao Y; Wu Z; McGoogan JM; Shi CX; Li A; Dou Z; Ma Y; Qin Q; Brookmeyer R; Detels R; Montaner JSG
Clin Infect Dis; 2018 Feb; 66(5):727-734. PubMed ID: 29069362
[TBL] [Abstract][Full Text] [Related]
13. Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China.
Cheng W; Wu Y; Wen Y; Ma Y; Zhao D; Dou Z; Zhang W; Bulterys M; Zhang F
Bull World Health Organ; 2015 Mar; 93(3):152-60. PubMed ID: 25838611
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
[TBL] [Abstract][Full Text] [Related]
15. Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study.
Eholié SP; Ello FN; Coffie PA; Héma A; Minta DK; Sawadogo A
Trop Med Int Health; 2017 Sep; 22(9):1186-1195. PubMed ID: 28653454
[TBL] [Abstract][Full Text] [Related]
16. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of cotrimoxazole in people with advanced HIV infection initiating antiretroviral therapy in sub-Saharan Africa.
Abimbola TO; Marston BJ
J Acquir Immune Defic Syndr; 2012 May; 60(1):e8-e14. PubMed ID: 22240461
[TBL] [Abstract][Full Text] [Related]
18. Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
Hoffmann CJ; Fielding KL; Charalambous S; Innes C; Chaisson RE; Grant AD; Churchyard GJ
AIDS; 2010 Jul; 24(11):1709-16. PubMed ID: 20495439
[TBL] [Abstract][Full Text] [Related]
19. Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi.
Lowrance D; Makombe S; Harries A; Yu J; Aberle-Grasse J; Eiger O; Shiraishi R; Marston B; Ellerbrock T; Libamba E
J Acquir Immune Defic Syndr; 2007 Sep; 46(1):56-61. PubMed ID: 17972365
[TBL] [Abstract][Full Text] [Related]
20. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
